Soleus Capital Management’s Immunic IMUX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.09M | Hold |
7,293,007
| – | – | 0.34% | 52 |
|
|
2025
Q1 | $7.95M | Hold |
7,293,007
| – | – | 0.57% | 42 |
|
|
2024
Q4 | $7.29M | Hold |
7,293,007
| – | – | 0.46% | 47 |
|
|
2024
Q3 | $12M | Hold |
7,293,007
| – | – | 0.93% | 35 |
|
|
2024
Q2 | $8.1M | Hold |
7,293,007
| – | – | 0.71% | 45 |
|
|
2024
Q1 | $9.63M | Buy |
7,293,007
+6,993,007
| +2,331% | +$9.23M | 0.71% | 40 |
|
|
2023
Q4 | $450K | Hold |
300,000
| – | – | 0.05% | 68 |
|
|
2023
Q3 | $441K | Hold |
300,000
| – | – | 0.04% | 89 |
|
|
2023
Q2 | $753K | Hold |
300,000
| – | – | 0.08% | 89 |
|
|
2023
Q1 | $447K | Buy |
+300,000
| New | +$447K | 0.05% | 74 |
|
|
2022
Q4 | – | Sell |
-240,000
| Closed | -$758K | – | 79 |
|
|
2022
Q3 | $758K | Hold |
240,000
| – | – | 0.1% | 72 |
|
|
2022
Q2 | $833K | Hold |
240,000
| – | – | 0.13% | 69 |
|
|
2022
Q1 | $2.71M | Buy |
240,000
+65,000
| +37% | +$735K | 0.35% | 49 |
|
|
2021
Q4 | $1.68M | Buy |
+175,000
| New | +$1.68M | 0.17% | 53 |
|